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Abstract
Glioma C6 cells were transfected with a plasmid containing the calretinin (CR) and green fluorescent protein (GFP) coding
regions to analyze the effect of CR’s presence on [Ca2]i. Positive transfectants were identified by the detection of GFP and
[Ca2]i was measured using fura-2 as a probe. We found that neither the basic [Ca2]i nor activated [Ca2]i achieved by
exposure to ionomycin, ADP or thapsigargin were affected by CR’s presence in transfected cells, despite the ability of CR to
bind Ca2 as part of fusion protein. The level of expressed CR was estimated as at least 1 WM. The presented results suggest
that CR’s function is unlikely to be an intracellular Ca2-buffer and support the hypothesis that CR might be involved in a
specific Ca2-dependent process. The results of this work also show that the S65T mutant of GFP is compatible with fura-2
measurements of intracellular [Ca2]. We have demonstrated that the presence of GFP, as a transfection marker of glioma
C6 cells, does not disturb fura-2 fluorescence, the basal or activated [Ca2]i in these cells. ß 1999 Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
Ca2 plays a crucial regulatory role in eukaryotic
cells and its concentration must be strictly regulated.
Calcium binding proteins (CaBPs) are necessary to
allow Ca2 to induce many intracellular processes.
Only a few of the known CaBPs have a well de-
¢ned function, for example calmodulin and troponin
C, but the role of most CaBPs is still not fully under-
stood. Calretinin (CR) is a calcium binding protein
homologous to calbindin D28k (58% identical resi-
dues) consisting of 6 EF-hand calcium binding mo-
tifs [1^3]. CR is mostly present in the cytosol [4,5]
but it is also present in membrane fractions [5,6]. CR
is generally expressed in neurons [1,7] and is also
found in some cancer cell lines [8,9]. The function
of CR is not yet understood and so far, results
0167-4889 / 99 / $ ^ see front matter ß 1999 Published by Elsevier Science B.V. All rights reserved.
PII: S 0 1 6 7 - 4 8 8 9 ( 9 9 ) 0 0 0 1 0 - 5
Abbreviations: CR, calretinin; GFP, green £uorescent pro-
tein; CMV, cytomegalovirus promoter; [Ca2]i, intracellular cal-
cium concentration; PBS, phosphate-bu¡ered saline; TBS, Tris-
bu¡ered saline; SDS, sodium dodecyl sulfate; G-418, geneticin;
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have been published that provide an inconsistent pic-
ture. Some evidence suggest that the possible func-
tion of CR is the bu¡ering of intracellular [Ca2]
which protects cells against Ca2-overload [10^16].
However, it has been shown that CR changes its
conformation upon Ca2 binding with similar char-
acteristics as calmodulin, thus behaving like a typical
Ca2 sensor [17^19]. Also, there are data indicating
that the presence of CR in neurons does not provide
them with a greater resistance to Ca2-overload [20^
23]. When PC12 cells were transfected with plasmids
to express CR they did not achieve a stronger resist-
ance to Ca2-overload compared to the total popu-
lation of the studied cells [24]. The aim of the present
studies was to explain the latter results and to shed
more light on possible CR functions, and check
whether CR may act as a Ca2-bu¡er. We analyzed
the [Ca2]i before and after cell activation in cells
di¡ering in CR expression levels resulting from trans-
fection. The cells expressing CR were identi¢ed by
GFP £uorescence, whereas [Ca2]i was measured us-
ing fura-2. The [Ca2]i was simultaneously analyzed
in transfected cells showing GFP £uorescence and
untransfected cells showing no GFP £uorescence.
2. Materials and methods
2.1. Chemicals
Minimal essential medium (MEM), newborn calf
serum, fetal calf serum, trypsin-EDTA 1Usolution
and lipofectamine reagent were purchased from Gib-
co BRL; G-418, thapsigargin, ionomycin, 4-chloro-
1-naphthol and anti-rabbit IgG conjugated with
horseradish peroxidase were purchased from Sigma;
the green £uorescent protein vector (mutant S65T,
which has a single excitation peak at approximately
490 nm, and several fold more intense £uorescence
than wild-type GFP) was from Clontech; fura-2 AM
was obtained Molecular Probes and ADP from Ser-
va; low molecular mass standards were from Phar-
macia, and the Chemiluminescent Substrate kit came
from KPL (Kirkegaard and Perry Laboratories).
2.2. Cell culture
Glioma C6 cells were cultured in Hank’s MEM
supplemented with 7% (v/v) newborn calf serum,
penicillin (50 IU/ml) and streptomycin (50 Wg/ml).
The media was changed every 2^3 days and cells
were passaged when con£uent. Cultures were main-
tained in the presence of 5% CO2 at 37‡C. HCV
(human urothelial cells) were cultured in Eagle’s
MEM in the presence of 7% (v/v) fetal calf serum
and penicillin/streptomycin, and cultured as de-
scribed above.
2.3. Transfection
Two constructs were used for transfection experi-
ments: one encoding a GFP^calretinin fusion protein
and a second encoding only GFP. Both constructs
were under the control of the CMV promoter [24].
The plasmids were puri¢ed from Escherichia coli
(DH5K) using a QIAGEN Plasmid kit according to
the manufacturer’s protocols. Before transfection,
cells were trypsinized and resuspended in the culture
medium. About 1U106 cells and 40 Wg of DNA were
mixed and incubated on ice for 10 min. Electropora-
tion was then performed in 0.4-mm cuvettes using a
BioRad apparatus at 350 V, 500 WFD capacitance,
and the cells were again incubated on ice for 10 min.
The cells were then placed on coverslips and cultured
for 2 days under normal conditions. GFP £uores-
cence was analyzed on a Nikon Diaphot inverted
microscope to identify the e⁄ciency of transfection.
The transfection of HCV cells was performed us-
ing lipofectamine according to the manufacturer’s
protocols. Stable clones were selected using the anti-
biotic G-418 (500 Wg/ml). The transfected cells were
cultured under the conditions described above. GFP
£uorescence was analyzed on an inverted micro-
scope.
2.4. Measurement of the [Ca2+]i
The cytoplasmic level of calcium was examined
using a video imaging system (MagiCal, Applied
Imaging, data processing using Tardis V8.0 (Joyce
Loebl)) in single glioma C6 cells as described by Bar-
an¤ska et al. [25]. The cells for these experiments were
placed on glass coverslips and cultured for 2 days
under normal conditions before analysis. Next, cells
were washed once with PBS and once with a bu¡er
containing: 137 mM NaCl, 2.7 mM KCl, 1 mM
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Na2HPO3, 25 mM glucose, 20 mM Hepes (pH 7.4),
1 mM MgCl2, 1% (v/v) bovine serum albumin and
2 mM CaCl2. Cells were then incubated at 37‡C in
the above bu¡er with 1 WM fura-2 AM for 30 min.
After incubation, the cells were washed three times
with the same bu¡er solution but without fura-2.
Coverslips were mounted in a chamber over a Nikon
Diaphot inverted stage microscope (40U oil-immer-
sion objective lens, at 37‡C). All substances added
during subsequent experiments (Ca2-ionophore,
EGTA, thapsigargin or ADP) were dissolved in the
above bu¡er. The cells were alternatively illuminated
with 340 and 380 nm light wavelengths from a xenon
lamp. The emitted light was passed through a 510
nm barrier ¢lter into an image-intensi¢ed camera
(Extended ISIS, Photonic Science). The 340 nm and
380 nm images were software averaged and captured
every 2.85 s. The 340 nm and 380 nm signals were
examined for real changes in [Ca2]i. Ratio (R)
values were converted to an estimate of [Ca2]i
using the Grynkiewicz formula [26]: [Ca2]i =
Kd L (R3Rmin)/(Rmax3R). An intracellular calibra-
tion was carried out by the addition of 2 WM iono-
mycin to glioma C6 cells placed in a solution con-
taining 2 mM Ca2 (Rmax) and in 5 mM EGTA
(Rmin). The L value of 4.5 and Kd of 224 nM was
assumed. Positive transfectants containing GFP
were identi¢ed before [Ca2]i measurements using a
490 nm ¢lter.
2.5. Ca2+ binding by GFP^CR fusion protein
A protein fraction containing the GFP^CR fusion
protein was obtained from stable transfected HCV
cells. These cells were chosen because they yielded
a higher amount of GFP^CR than transiently trans-
fected glioma C6 cells (with an average e⁄ciency of
about 6%). Cells were homogenized with bu¡er (50
mM Tris^HCl, 20 mM NaCl, 1 mM EGTA, pH 8.0)
and sonicated. Proteins present in the 18 000Ug
supernatant were separated by SDS^polyacrylamide
(15%)-gel electrophoresis (PAGE) and transferred to
nitrocellulose in a Bio-Rad Trans-Blot apparatus at
200 mA for 1.5 h at room temperature with a trans-
fer bu¡er containing 192 mM glycine, 25 mM Tris,
0.1% SDS and 20% methanol (v/v). After protein
transfer, the nitrocellulose ¢lter was washed (3U20
min) in a bu¡er containing 60 mM KCl, 10 mM
imidazole/HCl and 5 mM MgCl2, pH 6.8. The nitro-
cellulose ¢lter was then incubated for 10 min with 0.1
mCi of 45CaCl2 (Amersham) in 20 ml of the above
bu¡er as described by Maruyama [27]. Subsequently,
the nitrocellulose was washed with 50% ethanol (v/v)
for 5 min and dried out. Autoradiographs were pro-
duced by exposure for 48^72 h. For the immunode-
tection of CR, the nitrocellulose ¢lter was washed in
TBS (2U10 min) and blocked by 3% BSA for 12 h,
37‡C. The nitrocellulose ¢lter was then incubated
with anti-calretinin serum (1:3000, NO6) for 2 h
and then with anti-rabbit IgG conjugated with horse-
radish peroxidase (1:1000). Staining was performed
using the chloronaphthol reaction.
2.6. Measurement of CR concentration expressed in
transfected cells
After transfection, the total number of cells and
positive transfectants were counted. The cells were
then trypsinized, washed once with PBS, homogen-
ized in a bu¡er containing 50 mM Tris^HCl, 20 mM
NaCl, 1 mM EGTA (pH 8.0), and sonicated. 10 Wg
of soluble proteins present in the 18 000Ug super-
natant were separated by SDS^polyacrylamide
10%-gel electrophoresis and transferred to nitrocellu-
lose in a Bio-Rad Trans-Blot apparatus at 200 mA
for 1.5 h with a transfer bu¡er containing 192 mM
glycine, 25 mM Tris, 0.1% SDS and 20% methanol
(v/v). The nitrocellulose ¢lter was washed in TBS
(2U10 min) and blocked by 3% BSA for 12 h,
37‡C and then incubated with anti-calretinin serum
(1:5000, NO6) for 2 h, and ¢nally with anti-rabbit
IgG conjugated with horseradish peroxidase for 1 h
(1:1000, Sigma). The CR antibody binding was esti-
mated on ¢lms by optical density measurements
(densitometer Molecular Dynamics) of the bands de-
veloped after reaction with chemiluminescent sub-
strates (KPL). Di¡erent time exposures from two
independent blots were used for densitometric anal-
ysis. As a quantitative standard, recombinant CR
puri¢ed from Escherichia coli [28] was used to esti-
mate the concentration of GFP^CR expressed in
transfected cells.
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3. Results
3.1. Transfection of glioma C6 cells
To analyze the e¡ects of CR’s presence on the
properties of glioma C6 cells we transfected them
with a plasmid containing the GFP and CR coding
regions. Transfected cells were identi¢ed by GFP £u-
orescence, which was visible about 24 h after electro-
poration (Fig. 1B). Di¡erent methods of transfection
were investigated. The most e⁄cient transfection was
obtained by electroporation with an average e⁄-
ciency of about 6% (range 3^15%) (as described in
Section 2) and this was used throughout the studies
reported here. Transfection using liposomes was le-
thal for cells and transfection by calcium phosphate
gave a low e⁄ciency (V1%). Transfected cells were
used 48 h after electroporation.
3.2. GFP £uorescence does not interfere with fura-2
£uorescence
The ¢rst experiments were designed to determine
whether the £uorescence of the S65T mutant of GFP
interferes with fura-2 £uorescence. We found that
cells containing GFP have the same fura-2 £uores-
cence as untransfected ones (Fig. 1A,B). Therefore,
the use of the S65T mutant of GFP as a marker of
successful transfection is compatible with the use of
fura-2 to measure intracellular [Ca2].
3.3. Intracellular [Ca2+] in cells expressing GFP
We examined whether the presence of GFP a¡ects
[Ca2]i in glioma C6 cells. The changes of [Ca2]i in
cells expressing GFP and in untransfected cells were
compared to each other, both before and after stim-
ulation with ionomycin, ADP and thapsigargin. All
the analyzed untransfected cells (82) and the cells
expressing GFP (56 cells analyzed) had a similar
average basal [Ca2]i. After the addition of 4 WM
ionomycin, all analyzed untransfected cells (23)
showed a very similar increases in [Ca2]i to those
observed in cells expressing GFP (19 cells). Fig. 2A
shows the results in which the [Ca2]i values for all
the analyzed cells were averaged.
After stimulation with 10 WM ADP, 25 untrans-
fected cells out of 33 analyzed (8 did not react)
showed a similar increase in the [Ca2]i as 19 cells
out of 23 analyzed expressing GFP (4 did not react).
Fig. 3A shows the results of a single experiment in
which the [Ca2]i values for analyzed cells (4 trans-
fected and 2 untransfected) were averaged.
After stimulation with 200 nM thapsigargin, 26
untransfected cells showed a similar increase of
[Ca2]i as 14 cells (all cells reacted) expressing
GFP. Fig. 4A shows the results of a single experi-
ment in which the [Ca2]i values for analyzed cells (3
transfected and 5 untransfected) were averaged. All
Fig. 1. Glioma C6 cells transfected with the GFP vector. (A)
Fura-2 £uorescence (black arrows show transfected cells, white
arrows show untransfected cells). (B) GFP control vector £uo-
rescence, with the same ¢eld of observation (arrows show the
same cells as indicated in A). U400.
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the results suggest that neither GFP expression, nor
the transfection process per se, a¡ects the [Ca2]i in
glioma C6 cells.
3.4. Intracellular [Ca2+] in cells expressing GFP^CR
fusion protein
The changes in [Ca2]i in cells expressing GFP^CR
and untransfected cells were compared with each
other, ¢rst before and then after stimulation with
ionomycin, ADP and thapsigargin. Untransfected
cells (85 analyzed) had a similar average basal
[Ca2]i level as cells expressing GFP^CR (63 ana-
lyzed). After the addition of 4 WM ionomycin, all
untransfected cells that were analyzed (48 cells)
showed a very similar increase in [Ca2]i to cells ex-
pressing GFP^CR (20 cells). Fig. 2B shows the re-
sults in which [Ca2]i values for all analyzed cells
were averaged.
After stimulation with 10 WM ADP, 18 from 20
untransfected cells showed an identical increase in
[Ca2]i as was observed in 19 cells from 20 analyzed
Fig. 2. Changes in [Ca2]i in glioma C6 cells stimulated with 4 WM ionomycin. (A) cells (n = 19) transfected with the GFP control vec-
tor (shown with crosses) versus untransfected ones (n = 23). (B) Cells transfected with GFP^CR (n = 20) (shown with closed circles)
versus untransfected ones (n = 48). Arrows show when ionomycin was added.
Fig. 3. Changes in [Ca2]i in glioma C6 cells stimulated with 10 WM ADP. (A) cells (n = 4) transfected with GFP control vector
(shown with crosses) versus untransfected ones (n = 2). (B) Cells transfected with GFP^CR (n = 3) (shown with closed circles) versus
untransfected ones (n = 5). Arrows show when ADP was added.
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(1 did not react) expressing GFP^CR. Fig. 3B shows
the results of a single experiment in which the [Ca2]
values for analyzed cells (3 transfected and 5 un-
transfected) were averaged.
After stimulation with 200 nM thapsigargin, 17
untransfected cells showed a similar increase in
[Ca2]i as observed in 23 cells expressing GFP^CR
(all cells reacted). Fig. 4B shows the results of a
single experiment in which the [Ca2] values for an-
alyzed cells (4 transfected and 4 untransfected) were
averaged. All the results indicate that GFP^CR does
not a¡ect the [Ca2]i in these cells, either before or
after activation.
3.5. Estimation of CR concentration in transfected
cells
The protein extract of cells expressing GFP^CR
was resolved by SDS^PAGE and blotted onto nitro-
cellulose to estimate the concentration of the fusion
protein. In neighboring wells, known amounts of re-
combinant CR were run as a quantitative standard.
The densitometric analysis of bands containing
known amounts of CR was used to obtain a calibra-
tion curve from which the amount of GFP^CR was
calculated (Fig. 5). It was found that the CR concen-
tration in stable transfected HCV cells was 0.009 pg
per cell and in transient transfected glioma C6 cells
was about 0.028 pg per cell, assuming an equal ex-
pression level in all cells transfected with 15% e⁄-
ciency. However, 4% of cells showed brighter GFP
£uorescence than the other transfected cells and only
those cells were used for Ca2 imaging experiments.
Based on the results by Staub et al. that the volume
of glioma C6 cells is about 900 Wm3 [29], the concen-
tration of CR is estimated to be at about 1.0 WM if
all transfected cells are accounted and assumed to
have an equal level of GFP^CR. The bright cells
Fig. 4. Changes in [Ca2]i in glioma C6 cells stimulated with 200 nM thapsigargin. (A) Cells (n = 3) transfected with GFP control vec-
tors (shown with crosses) versus untransfected ones (n = 5). (B) Cells transfected with GFP^CR (n = 4) (shown with closed circles) ver-
sus untransfected ones (n = 4). Arrows show when thapsigargin was added.
Fig. 5. Estimation of CR content in protein extracts of trans-
fected cells using immunoblotting. (A) Densitometric analysis of
the blots. (B) Film exposed after chemiluminescent reaction of
the blot. 1, 10 ng of recombinant CR; 2, 5 ng of CR; 3, 10 Wg
of untransfected glioma C6 cells protein extract; 4, 10 Wg of
GFP^CR transfected glioma C6 cells protein extract; 5, 10 Wg
of untransfected HCV cells protein extract; 6, 10 Wg of GFP^
CR transfected HCV cells protein extract.
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used for Ca2 imaging experiments had a higher level
of GFP^CR but this is di⁄cult to estimate accu-
rately.
3.6. Ca2+ binding by GFP^CR fusion protein
It was earlier shown that a glutathione-S-transfer-
ase^CR fusion protein exhibits a Ca2-binding abil-
ity similar to that of recombinant CR [28]. The re-
sults in Fig. 6 con¢rm that CR is able to bind Ca2
as a fusion product with GFP. Therefore, the lack of
e¡ects of GFP^CR on the Ca2 level cannot be ex-
plained by an inability of the GFP^CR fusion pro-
tein to bind Ca2. Rather, it suggests that CR is
unable to signi¢cantly a¡ect Ca2 homeostasis in
transfected glioma C6 cells.
4. Discussion
As reviewed in the Section 1, several studies sug-
gest that the presence of CR correlates with an in-
creased survival ability of neurons under pathologi-
cal conditions which are connected with increased
intracellular levels of Ca2 [10^12,16]. However,
not all studies con¢rm such a relationship. It has
often been postulated that CR does not act as
Ca2 bu¡er and protect neurons against Ca2-over-
load [20^23]. As CR-positive cells and CR-negative
cells were maintained under the same conditions
throughout the experiments, it was possible to di-
rectly and simultaneously compare their properties.
We found that neither the basic [Ca2]i, nor acti-
vated levels, were a¡ected by CR’s presence (as
part of a fusion protein) in transfected cells despite
CR’s ability to bind Ca2, as shown in this work and
by Strauss et al. [28]. The apparent lack of Ca2
bu¡ering by CR supports our earlier work showing
that cells overexpressing CR do not show better sur-
vival rates when treated with Ca2-ionophores [24].
Thus, our present results support the hypothesis that
CR’s function is unlikely to be an intracellular Ca2
bu¡er [18]. However, the results of the present work
are in contrast to the meeting report by Fellay et al.,
who observed a Ca2 bu¡ering e¡ect with CR over-
expression [30]. This discrepancy is di⁄cult to ex-
plain but some suggestions can be proposed. The
di¡erent results could be explained by the di¡erent
methods of transfection used, its prevalence (stable
versus transient transfection), the di¡erent cell lines
used in the experiments and di¡erent agents used to
induce the Ca2 signal (those mobilizing Ca2 from
the endoplasmic reticulum, or those which cause a
Ca2 in£ux from the extracellular space). It is possi-
ble that the e¡ect of CR can only be seen in those
cell lines in which CR and its targets are present. In
di¡erent cell lines the level of expression of the re-
combinant protein may vary and a di¡erent com-
partmentalization might a¡ect the ability of the pro-
tein to react to [Ca2] changes. Such explanations
were provided by Braunewell et al., who found a
similar [Ca2]i in both visinin-like protein transfected
and untransfected glioma C6 cell lines [31]. Compart-
mentalization of Ca2 pools and their di¡erent mo-
bilization, depending on the type of stimuli, is a
likely explanation for the di¡erent e¡ect of serum
versus Ca2 ionophores on stable cell lines expressing
calbindin D28k [32].
To bu¡er [Ca2]i from 0.7 WM (achieved by ion-
omycin) to, for instance, 0.5 WM, it would be enough
to have at least 0.15 WM of intracellular CR (assum-
ing four calcium ions bound). We estimate the level
of GFP^CR in glioma C6 cells to be at least 1 WM
(0.028 pg per cell). The endogenous concentration of
CR in neurons is unknown but it was reported that
the homologous protein, calbindin D28k, is present
at 0.05 pg per Purkinje cell in the rat cerebellum [33].
If the endogenous CR concentration is similar to
Fig. 6. Ca2 binding by GFP^CR fusion protein. (A) Protein
staining with Ponceau Red. (B) Autoradiogram with 45Ca2-
binding on the same blot. (C) Western blot with anti-CR stain-
ing of the same blot (GFP^CR is indicated with arrow).
1, supernatant of control HCV cell extract after centrifugation
at 18 000Ug ; 2, supernatant of GFP^CR transfected HCV cell
extract after centrifugation at 18 000Ug.
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that of calbindin D28k then the concentration of
GFP^CR is similar to the CR concentration in neu-
rons. Therefore, we believe that the level of expressed
GFP^CR in glioma C6 cells is either within the phys-
iological concentration of endogenous CR, or higher.
If so, CR should act as a Ca2 bu¡er in our exper-
imental system. However, even this level of CR does
not a¡ect an activated level of [Ca2] reaching 700
nM (Fig. 2). An unlikely explanation is that the pres-
ence of GFP decreases the ability of CR to bind
Ca2 ; GST in a fusion product with CR seems not
to have such an e¡ect [28].
Is CR, then, a general intracellular [Ca2] bu¡er-
ing protein? We believe that results of this work, and
of our earlier work, do not support such a hypoth-
esis. However, many authors propose that this is the
case and claim that this is the function of this pro-
tein. If the role of CR is to bu¡er [Ca2], in other
words to perform a crucial function for neuron sur-
vival, it is di⁄cult to explain the results in which
mice lacking calretinin were studied [34]. First, the
brain development appeared to be normal in these
mice and there was no evidence the for up-regulation
of other calcium binding proteins. Second, the lack
of CR expression did not a¡ect motor coordination
while the lack of calbindin D28k signi¢cantly im-
paired motor coordination [35], [34]. Why would
two similar ‘bu¡er-proteins’ behave so di¡erently?
Third, CR de¢cient mice showed no alteration in
basal synaptic transmission, whereas long-term po-
tentiation was impaired in the dentate gyrus. These
results, as well as the published results on the possi-
ble neuroprotection provided by CR, might be ex-
plained if CR is involved in Ca2 modulation of
speci¢c signaling pathways rather than in overall
general intracellular [Ca2] bu¡ering. Therefore, the
term ‘Ca2 bu¡er’ for CR seems to be justi¢ed only
to distinguish it from proteins called ‘Ca2 sensors’
such as calmodulin. It seems more appropriate to
name CR a ‘Ca2 modulator’ to distinguish it from
genuine Ca2 bu¡ers such as parvalbumin or calbin-
din D9k and to more accurately describe its function.
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